Literature DB >> 339857

The chemotherapy of rodent malaria, XXVIII. The development of resistance to mefloquine (WR 142,490).

W Peters, J Portus, B L Robinson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 339857     DOI: 10.1080/00034983.1977.11687207

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


× No keyword cloud information.
  11 in total

1.  Genetics of mefloquine resistance in the rodent malaria parasite Plasmodium chabaudi.

Authors:  Pedro V L Cravo; Jane M-R Carlton; Paul Hunt; Laura Bisoni; Rose Ann Padua; David Walliker
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

2.  A phase I clinical trial of Fansimef (mefloquine plus sulfadoxine-pyrimethamine) in Brazilian male subjects.

Authors:  J M de Souza; U K Sheth; R M de Oliveira; A T Gomes; E Q Cavalcante
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

Review 3.  Resistance of Plasmodium falciparum.

Authors:  E B Doberstyn
Journal:  Experientia       Date:  1984-12-15

Review 4.  New answers through chemotherapy?

Authors:  W Peters
Journal:  Experientia       Date:  1984-12-15

5.  Antimalarial activities of various 4-quinolonemethanols with special attention to WR-142,490 (mefloquine).

Authors:  L H Schmidt; R Crosby; J Rasco; D Vaughan
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

6.  A double-blind clinical trial of a combination of mefloquine, sulfadoxine and pyrimethamine in symptomatic falciparum malaria.

Authors:  J M Ekue; O O Simooya; U K Sheth; W H Wernsdorfer; E K Njelesani
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

Review 7.  Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  K J Palmer; S M Holliday; R N Brogden
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

8.  Falciparum malaria treated with a fixed combination of mefloquine, sulfadoxine and pyrimethamine: a field study in adults in Burma.

Authors:  F Tin; N Hlaing; T Tun; S Win; R Lasserre
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

9.  The pharmacokinetics of mefloquine when given alone or in combination with sulphadoxine and pyrimethamine in Thai male and female subjects.

Authors:  J Karbwang; D Bunnag; A M Breckenridge; D J Back
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

10.  Evidence for the contribution of the hemozoin synthesis pathway of the murine Plasmodium yoelii to the resistance to artemisinin-related drugs.

Authors:  Benoit Witkowski; Joel Lelièvre; Marie-Laure Nicolau-Travers; Xavier Iriart; Patrice Njomnang Soh; Fatima Bousejra-Elgarah; Bernard Meunier; Antoine Berry; Françoise Benoit-Vical
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.